Numbers of RUNX2+ cells (Figure 6, E–H, quantified in Figure 6I) and osterix+ cells (Figure 6, J–M, quantified in Figure 6N) decreased in the T2D PDLs compared with those in controls, but Scl-Ab treatment increased both cell populations in the PDL. Here, RUNX2 is linked to type 2 diabetes mellitus.